Weekly News Round-up – 19/6/20
3 years ago
By Josh Neil
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts trialling in children with the illness. In other news, a cheap steroid has been found to reduce fatalities from Covid-19, and the UK halts all hydroxychloroquine trial recruitment.
VACCINE DEMAND RISES AS COUNTRIES PREPARE FOR SECOND WAVE – Worries of a second wave of Covid-19 sweeping the globe have led to a rush for influenza shots in countries attempting to vaccinate large parts of their population to reduce pressure on health services. While mass immunisation would reduce the number of individuals getting flu this year, doubts have been raised that companies can provide the necessary number in time.
GILEAD TO TEST REMDESIVIR IN CHILDREN WITH COVID-19 – Gilead’s anti-Covid drug remdesivir will soon start trials in children with moderate to severe Covid-19. The phase 2/3 trial will use 50 patients at over 30 clinical sites. It should be completed by the end of 2020.
CHEAP STEROID LABELLED ‘MAJOR BREAKTHROUGH’ FOR LOWERING COVID DEATHS – An Oxford University study testing Covid-19 drug candidates has found daily doses of steroid dexamethasone reduces the death rate across the board in patients who required support due to respiratory distress. This drug is the first to show increased survival rates after remdesivir failed in that area.
In other news:
R&D
Sarepta and Selecta agree R&D gene therapy deal
Clinical Trials
Two Roche products in Covid and prostate cancer produce mixed results
UK halts hydroxychloroquine trial recruitment
Manufacturing
Emergent begins $75 million expansion to produce viral vectors
That’s all for now. See you next week!
Joshua Neil, Editor
Proventa International
To ensure you remain up-to-date on the latest in clinical development, sign up for Proventa International’s online Clinical Operations, Supply Chain & Pharmacovigilance Strategy Meeting 2020.
RNA Therapeutics: The World’s First mRNA Malaria Vaccine
Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....
2 years agoRNA Therapeutics: The World’s First mRNA Malaria Vaccine
Malaria represents one of the greatest unmet clinical needs in the world. In the last decade, research has been ongoing to develop effective preventative methods and effective treatment to reduce the risk of severe illness, which typically occurs in children....
2 years ago
Raising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
2 years agoRaising Representation in Clinical Trials: An Interview with Liz Beatty, Inato
The COVID-19 pandemic created a significant shortage of suitable patients for clinical trials worldwide. Within this crisis was another more serious issue around inclusion and representation, driven by COVID’s disparate effect on certain ethnicities, that spoke to a wider issue...
2 years ago
Intrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets
Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...
2 years agoIntrinsically Disordered Proteins – The Implication in Cancer and Potential Drug Targets
Intrinsically disordered proteins (IDPs) are under the limelight in cancer research. While research is continuous in understanding their dynamic structure, their implication in tumour development is becoming increasingly evident. Some of the latest advancements demonstrate how IDPs can be used...
2 years ago